Neurology : what's new in 2022
The year 2022 was marked by the development of numerous new treatments for refractory myasthenia gravis. The link between epilepsy and cerebrovascular disorder was studied and lamotrigine discovered to be the optimal treatment choice for epilepsy secondary to stroke to prevent mortality on patient of 45 years and older. New randomized study finally demonstrated the utility of thrombectomy in selected patients with basilar artery occlusion. The causal relationship between Epstein-Barr infection and multiple sclerosis has been proved thanks to a large cohort study. A new possibility of subcutaneous continuous levodopa administration gave promising result. Finally, numerous studies confirmed the efficacy and excellent tolerability of anti-CGRP antibodies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Revue medicale suisse - 19(2023), N° 809-10 vom: 18. Jan., Seite 42-45 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Neurologie : ce qui a changé en 2022 |
|---|
| Beteiligte Personen: |
Bouvy, Céline [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.01.2023 Date Revised 23.01.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.53738/REVMED.2023.19.809-10.42 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351715894 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351715894 | ||
| 003 | DE-627 | ||
| 005 | 20231226052038.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.53738/REVMED.2023.19.809-10.42 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1172.xml |
| 035 | |a (DE-627)NLM351715894 | ||
| 035 | |a (NLM)36660836 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Bouvy, Céline |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurology |b what's new in 2022 |
| 246 | 3 | 3 | |a Neurologie : ce qui a changé en 2022 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.01.2023 | ||
| 500 | |a Date Revised 23.01.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The year 2022 was marked by the development of numerous new treatments for refractory myasthenia gravis. The link between epilepsy and cerebrovascular disorder was studied and lamotrigine discovered to be the optimal treatment choice for epilepsy secondary to stroke to prevent mortality on patient of 45 years and older. New randomized study finally demonstrated the utility of thrombectomy in selected patients with basilar artery occlusion. The causal relationship between Epstein-Barr infection and multiple sclerosis has been proved thanks to a large cohort study. A new possibility of subcutaneous continuous levodopa administration gave promising result. Finally, numerous studies confirmed the efficacy and excellent tolerability of anti-CGRP antibodies | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Caranzano, Leonardo |e verfasserin |4 aut | |
| 700 | 1 | |a Allali, Gilles |e verfasserin |4 aut | |
| 700 | 1 | |a Bally, Julien |e verfasserin |4 aut | |
| 700 | 1 | |a Benninger, David |e verfasserin |4 aut | |
| 700 | 1 | |a Beuchat, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Castro Jimenez, Mayté |e verfasserin |4 aut | |
| 700 | 1 | |a Di Virgilio, Gabriella |e verfasserin |4 aut | |
| 700 | 1 | |a Hirt, Lorenz |e verfasserin |4 aut | |
| 700 | 1 | |a Michel, Patrik |e verfasserin |4 aut | |
| 700 | 1 | |a Novy, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Pot Kreis, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Rossetti, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Rouaud, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Ryvlin, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Salvioni Chiabotti, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Sokolov, Arseny |e verfasserin |4 aut | |
| 700 | 1 | |a Strambo, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Théaudin, Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Du Pasquier, Renaud |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revue medicale suisse |d 2005 |g 19(2023), N° 809-10 vom: 18. Jan., Seite 42-45 |w (DE-627)NLM154244252 |x 1660-9379 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2023 |g number:N° 809-10 |g day:18 |g month:01 |g pages:42-45 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.53738/REVMED.2023.19.809-10.42 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2023 |e N° 809-10 |b 18 |c 01 |h 42-45 | ||